PROPIVERINE HYDROCHLORIDE 15MG COATED TABLETS
Active substance(s): PROPIVERINE HYDROCHLORIDE / PROPIVERINE HYDROCHLORIDE / PROPIVERINE HYDROCHLORIDE
Package leaflet: information for the patient
Detrunorm®15 mg Coated Tablets
Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This leaflet provides a summary of the information available on your
This medicine has been prescribed for you, do not pass it on to others, it
may harm them, even if their symptoms are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes
any possible side effects not listed in this leaflet. See section 4.
In this leaflet:
1. What detrunorm 15 mg coated tablets are and what they are used for
2. What you need to know before you take Detrunorm 15 mg Coated Tablets
3. How to take Detrunorm 15 mg Coated Tablets
4. Possible Side Effects
5. How to store Detrunorm 15 mg Coated Tablets
6. Contents of the pack and other information
WHAT DETRUNORM 15 MG COATED TABLETS ARE AND WHAT
THEY ARE USED FOR
The name of your medicine is Detrunorm 15 mg Coated Tablets (to be referred
to as Detrunorm throughout the leaflet).
Detrunorm is used for the treatment of people who have difficulty in controlling
their bladders due to bladder overactivity or, in some cases, problems with the
spinal cord. Detrunorm contains the active substance propiverine hydrochloride.
This substance prevents the bladder from contracting and increases the amount
that the bladder can hold. Detrunorm is used to treat the symptoms of
WHAT YOU NEED TO KNOW BEFORE YOU TAKE DETRUNORM 15 MG
Do not take Detrunorm if:
• You are allergic (hypersensitive) to propiverine hydrochloride or any of
the other ingredients of Detrunorm listed in section 6 (allergic reactions
include mild symptoms such as itching and/or rash. More severe
symptoms include swelling of the face, lips, tongue and/or throat with
difficulty in swallowing or breathing).
or if you are suffering from any of the following condtions:
• obstruction of the bowel;
• obstruction to the bladder outlet (difficulty in passing urine);
• myasthenia gravis (a disease causing muscle weakness);
• a loss of function of the muscles controlling your bowel movements
• severe inflammation of the bowel (ulcerative colitis) that may lead to
diarrhoea containing blood and mucus and stomach pains;
• toxic megacolon (a condition involving enlargement of the bowel);
• increased pressure in the eye (uncontrolled angle closure glaucoma);
• moderate or severe liver disease;
• fast or irregular heartbeat.
180 x 300 mm
Black & Cutter
Warnings and precautions
Take special care with this medicine if you have:
• damage to the nerves that control blood pressure, heart rate, bowel and
bladder movement and other bodily functions (autonomic neuropathy);
• liver problems;
• kidney problems;
• severe heart failure;
• enlargement of the prostate gland;
• heartburn and indigestion due to back flow of gastric juice into the throat
(hiatus hernia with reflux oesophagitis);
• irregular heartbeat;
• fast heartbeat.
If you suffer from any of these conditions, contact your doctor. He/she will tell
you what to do.
Other medicines and Detrunorm
You should tell your doctor if you are taking or have taken any of the following
medicines as they may interact with Detrunorm:
• antidepressants (e.g. imipramine, clomipramine, amitryptiline);
• sleeping tablets (e.g. benzodiazepines);
• anticholinergics taken by mouth or injection (usually used to
treat asthma, stomach cramps, eye problems or urinary incontinence);
• amantadine (used to treat flu and Parkinson’s disease);
• neuroleptics such as promazine, olanzapine, quetiapine (drugs used to
treat psychotic disorders like schizophrenia and anxiety);
• beta stimulants (drugs used to treat asthma);
• cholinergics (e.g. drugs used to decrease the heartbeat, to stimulate the
digestion and to treat glaucoma as Carbachol, Pilocarpin);
• isoniazid (a treatment for tuberculosis);
• metoclopramide (used to treat nausea and vomiting).
Nevertheless, it may still be all right for you to take Detrunorm. Your doctor will
be able to decide what is suitable for you.
Please tell your doctor or pharmacist if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription.
Taking Detrunorm with food and drink
The tablets should be swallowed before meals.
Pregnancy and breast-feeding
Do not take Detrunorm if you are pregnant, likely to become pregnant or are
Driving and using machinery
Detrunorm Tablets can sometimes cause sleepiness and blurred vision. You
should not drive or operate machinery until you are sure you are not affected.
Important information about some of the ingredients of Detrunorm
Detrunorm Tablets contains glucose, lactose and sucrose (sugars). If you have
been told by your doctor that you have intolerance to some sugars, contact your
doctor before taking this medicine.
PAGE 1 OF 2
Detrunorm Tablets also contain the colouring agent Cochineal red A
May cause allergic reactions.
3. HOW TO TAKE DETRUNORM 15 MG COATED TABLETS
Always take Detrunorm exactly as your doctor has told you. You should check
with your doctor or pharmacist if you are not sure.
The label on the carton will tell you how many tablets to take and when. Take
your tablets at the same times each day. Swallow your tablets whole before
Adults and the elderly: the recommended dose of Detrunorm is two to
three tablets daily.
Detrunorm is not recommended for children.
If you take more Detrunorm than you should
If you accidentally take more than your prescribed dose, contact your nearest
casualty department or tell your doctor or pharmacist immediately.
Remember to take the pack and any remaining tablets with you. Overdosage
can cause symptoms such as restlessness, dizziness, vertigo, disorders in
speech and vision, muscular weakness, dry mouth, faster heartbeat and
problems passing urine.
If you forget to take Detrunorm
Do not worry. Simply leave out that dose completely. Then take your next
dose at the right time. Do not take a double dose to make up for a missed dose.
If you have any further questions on the use of this product, ask your doctor
4. POSSIBLE SIDE EFFECTS
Like all medicines, Detrunorm 15 mg Coated Tablets can cause side effects,
although not everybody gets them.
All medicines can cause allergic reactions although serious allergic reactions
are very rare. The following symptoms are first signs for such reactions:
• Any sudden wheeziness, difficulty in breathing or dizziness, swelling of
the eyelids, face, lips or throat;
• Peeling and blistering of the skin, mouth, eyes and genitals;
• Rash affecting your whole body.
If you get any of these symptoms during treatment, you should stop taking
the capsules and contact your doctor immediately.
You might suffer an acute attack of glaucoma. If you have been seeing
coloured rings around lights or if you should develop severe pain in and
around either eye you should seek medical attention urgently.
The following side effects have been reported:
Very Common (affects more than 1 user in 10)
Common (affects more than 1 to 10 users in 100)
Abnormal vision and difficulty in focussing, fatigue, headache, stomach pain,
Uncommon (affects 1 to 10 users in 1,000)
Feeling sick and vomiting, dizziness, trembling (tremor), difficulty in passing
urine (urinary retention), flushing, altered sense of taste, decreased blood
pressure with drowsiness.
Rare (affects 1 to 10 users in 10,000)
Very Rare (affects less than 1 user in 10,000)
Irregular heartbeat, restlessness and confusion.
Not known (frequency cannot be estimated from the available data)
Sensing things that are not real (hallucinations).
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. You can also report side effects
directly via the Yellow Card Scheme, website www.mhra.gov.uk/yellowcard. By
reporting side effects you can help provide more information on the safety of this
180 x 300 mm
Black & Cutter
HOW TO STORE DETRUNORM 15 MG COATED TABLETS
Keep this medicine out of sight and reach of children
Do not store the blister pack above 25°C.
There are no special precautions for storage.
Do not use after the expiry date which is stated on the carton after EXP.
The expiry date referees to the last day of that month.
CONTENTS OF THE PACK AND OTHER INFORMATION
What Detrunorm 15 mg Coated Tablets contain
Each tablet contains 15 mg propiverine hydrochloride (equivalent to 13.64 mg
propiverine) as the active ingredient along with the following other ingredients:
lactose monohydrate; powdered cellulose; magnesium stearate; sucrose; talc;
heavy kaolin; calcium carbonate; titanium dioxide (E171); acacia gum; colloidal
anhydrous silica; Macrogol 6000; glucose monohydrate; cochineal red A (E124,
lake); Montan wax.
What Detrunorm 15 mg Coated Tablets look like and the contents of
The tablets are rose-coloured sugar coated tablets. They are available in cartons
of 28 or 56 tablets.
Marketing Authorisation Holder:
Amdipharm UK Limited,
85 King William Street,
London EC4N 7BL, UK
Manufacturer responsible for release is:
APOGEPHA Arzneimittel GmbH,
The following organisations can offer independent advice:
The Continence Foundation
307 Hatton Square
16 Baldwin’s Gardens
London EC1N 7RJ
Help line Mon-Fri 9.30-4.30 Tel: 020 7831 9831
Incontact (Self help organisation for sufferers and carers)
London NW7 1YU
Tel: 020 7530 3401
Help line Mon-Fri 9.30 am – 1.00 pm Tel. 0845 345 0165
Detrunorm is a registered trademark of Amdipharm AG.
This leaflet was last revised in July 2014.
11985 / C41 / v002uk
PAGE 2 OF 2
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.